Home

OMAR ISHRAK

CIK 1523102 · Executive Chairman · last filed 2026-08-10

OMAR ISHRAK is an Executive Chairman who has filed 87 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing, for AMGN, was dated Aug 10, 2026. Across all open-market trades the lifetime net is −$28.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $62.4M across reported positions. 33 SEC filings were submitted jointly with Medtronic plc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$62.37M

Companies

4

Total Filings

87

Lifetime Open-Market Net

-$28.45M

Filer Profile

Reported Address
ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CA 91320
Related Filers
Medtronic plc — 33 joint filings, latest 2020-12-11
INTEL CORP — 23 joint filings, latest 2025-04-01
AMGEN INC — 22 joint filings, latest 2026-08-10
MEDTRONIC INC — 14 joint filings, latest 2015-01-28
Joshua A Fink — 3 joint filings, latest 2023-08-03
Jean Nehme — 3 joint filings, latest 2023-08-03
Compute Health Sponsor LLC — 2 joint filings, latest 2023-08-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AMGN Director 7,485 $381.50 $2.86M $0 20 2026-08-10
INTC Director 54,858 $97.19 $5.33M $1.46M 22 2025-04-01
ALLURION TECHNOLOGIES, INC. (ALUR.WS) Delisted Director 755,463 $0.01 $9.0K $0 1 2023-10-25
MDT Executive Chairman 577,632 $93.80 $54.18M -$29.91M 44 2020-12-11

Recent Filings

87 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-10 AMGN Grant (A) +85 $0 EDGAR
2026-05-21 AMGN Grant (A) +665 $0 EDGAR
2026-05-07 AMGN Grant (A) +106 $0 EDGAR
2025-11-12 AMGN Grant (A) +218 $0 EDGAR
2025-08-12 AMGN Grant (A) +121 $0 EDGAR
2025-05-28 AMGN Grant (A) +809 $0 EDGAR
2025-05-08 AMGN Grant (A) +129 $0 EDGAR
2025-04-01 INTC Grant (A) — $0 EDGAR
2024-12-31 INTC Grant (A) — $0 EDGAR
2024-11-06 AMGN Grant (A) +220 $0 EDGAR
Showing 1–10 of 87
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.